Arvind posts 14 per cent revenue growth in Q2

In a robust recovery from first-quarter challenges, Ahmedabad-based textile giant Arvind has returned to growth, reporting a 14% increase in revenue and a 7% rise in Ebitda for the second quarter of FY25. The company posted consolidated revenue of Rs 2,188 crore and Ebitda of Rs 221 crore, reflecting an Ebitda margin of 10.1%.

The quarter’s growth was driven by stable raw material costs and a favourable product mix, despite ongoing geopolitical challenges and uncertain macroeconomic conditions, the company said in a statement.

Denim volume reached its highest level in nine quarters, achieving approximately 90% utilisation, while the woven segment saw 11% growth, delivering 32.7 million meters at near-full capacity utilisation. The garmenting division recorded 21% growth, with volumes surpassing 9 million units and showing improved sequential realisations

Also Read Bikaji Foods Q2 Results: Profit rises by 13% to Rs 61.19 crore, revenue up 18.5% YoY on festive demand Bajaj Finserv Q2 Results: Profit rises by 8.2% to Rs 2,086.97 crore, revenue up 29.5% YoY L&T Tech posts Q2 profit at Rs 319.60 crore, revenue rises by 7.8% YoY; FY25 guidance maintained Isha Ambani’s Reliance Retail posts Q2 profit growth of 1.3% at Rs 2,836 crore, adds 464 new stores

Also ReadUbuy announces Diwali sale with free international shipping from Nov 1-3

“Volume growth in textiles is attributed to new customer acquisitions and better demand. AMD reported a 10% increase in volume, though order deferments in mass transport and a slower recovery in human protection led to growth below expectations,” the company said.

For Q2 FY25, the textile division posted its highest growth in nine quarters, with a 12% increase in revenue to Rs 1,633 crore and an Ebitda of Rs 168 crore, resulting in an Ebitda margin of 10.3%. AMD reported revenue of Rs 388 crore, a 9% growth, with Ebitda at Rs 60 crore, maintaining a margin of 15.3%.

Consolidated profit before tax for Q2 rose by 20% to Rs 135 crore, while profit after tax (PAT) stood at Rs 60 crore. Adjusted for changes in tax rates and one-time costs, PAT would have been approximately Rs 97 crore. An exceptional deferred tax expense of ₹29 crore, due to changes in the Finance Act 2024, raised tax costs, although it had no impact on cash flow.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth